Therapeutic Drug Monitoring of Biologic Agents in the Era of Precision Medicine

참고문헌 (9)

1. Yanai H, "Assessing response and loss of response to biological therapies in IBD", Am J Gastroenterol, 106, pp.685~698 (2011)
2. Vande Casteele N, "American Gastroenterological Association Institute technical review on the role of therapeutic drug monitoring in the management of inflammatory bowel diseases", Gastroenterology, 153, pp.835~857 (2017)
3. 최리화, "Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status Considerations", Annals of Laboratory Medicine, 37(2), pp.97~107 (2017), 대한진단검사의학회
4. Papamichael K, "Appropriate therapeutic drug monitoring of biologic agents for patients with inflammatory bowel diseases", Clin Gastroenterol Hepatol, 17, pp.1655~1668 (2019)
5. Papamichael K, "Therapeutic drug monitoring with biologic agents in immune mediated inflammatory diseases", Expert Rev Clin Immunol, 15, pp.837~848 (2019)
6. Choon Jin Ooi, "Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia", Intestinal research, 17(3), pp.285~310 (2019), 대한장연구학회[DOI]
7. Jourdil JF, "Simultaneous quantification of adalimumab and infliximab in human plasma by liquid chromatography-tandem mass spectrometry", Ther Drug Monit, 40, pp.417~424 (2018)
8. Willeman T, "A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: application for adalimumab therapeutic drug monitoring in patients with Crohn’s disease", Anal Chim Acta, 1067, pp.63~70 (2019)
9. Maurizio Benucci, "Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity", Annals of Laboratory Medicine, 40(2), pp.101~113 (2020), 대한진단검사의학회[DOI]

관련 논문AI추천